Internal Medicine, Pulmonary Disease · Coral Gables, FL
NPI
1720074545
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
747 Ponce de Leon Blvd, Suite 500
Coral Gables, FL, 33134
Phone (305) 648-1119
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
719 services
Medicare patients, 2024
230
Average age 76
Drug cost, 2024
$2.7M
16,367 prescriptions
Company payments, 2025
$633
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan C Acevedo-Crespo was code 99214 (office e&m - established), 330 times for 203 patients. In total Juan C Acevedo-Crespo billed 719 services in 12 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 330 | 203 | $107.93 | $36K |
| 94727 Pulmonary Function Testing | Office | 83 | 83 | $37.78 | $3,136 |
| 94729 Pulmonary Function Testing | Office | 83 | 83 | $47.81 | $3,968 |
| 94060 Pulmonary Function Testing | Office | 83 | 83 | $33.09 | $2,746 |
| 94618 Pulmonary Function Testing | Office | 60 | 59 | $28.66 | $1,720 |
| 99204 Office E&M - New | Office | 38 | 38 | $146.79 | $5,578 |
| 95811 Sleep Study | Office | 20 | 20 | $541.49 | $11K |
| 95810 Sleep Study | Office | 11 | 11 | $492.43 | $5,417 |
By year: 2022 $68K for 777 services; 2023 $76K for 814 services; 2024 $70K for 719 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan C Acevedo-Crespo prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 4,496 prescriptions and refills. In total Juan C Acevedo-Crespo wrote 16,367 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 4,496 | 4,870 | 1,166 | $125K |
| Fluticasone Propionate Generic | 2,850 | 4,624 | 910 | $40K |
| Montelukast Sodium Generic | 2,128 | 3,857 | 585 | $11K |
| Breo Ellipta Fluticasone/Vilanterol | 1,542 | 1,696 | 386 | $661K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,314 | 1,444 | 290 | $909K |
| Ventolin Hfa Albuterol Sulfate | 812 | 875 | 312 | $44K |
| Symbicort Budesonide/Formoterol Fumarate | 432 | 485 | 145 | $109K |
| Atrovent Hfa Ipratropium Bromide | 342 | 365 | 94 | $174K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 324 | 336 | 91 | $211K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 259 | 284 | 92 | $47K |
| Azelastine Hcl Generic | 224 | 360 | 73 | $7,243 |
| Breyna Budesonide/Formoterol Fumarate | 220 | 266 | 63 | $31K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 194 | 219 | 47 | $18K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 188 | 194 | 41 | $12K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 144 | 148 | 38 | $69K |
Brand drugs: 9,448 claims; generic drugs: 6,919 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan C Acevedo-Crespo $633 ($633 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $420.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.